Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)
3.020
-0.120 (-3.82%)
At close: Feb 13, 2026
SHA:600381 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 127.27 | 207.22 | 172.26 | 168.69 | 164.94 | 180.87 |
Short-Term Investments | - | - | - | 1.63 | - | - |
Trading Asset Securities | 0.75 | 0.74 | 0.67 | 0.66 | 34.65 | 31.63 |
Cash & Short-Term Investments | 128.02 | 207.96 | 172.93 | 170.98 | 199.59 | 212.5 |
Cash Growth | -11.35% | 20.26% | 1.14% | -14.33% | -6.08% | -37.11% |
Accounts Receivable | 84.7 | 70.99 | 62.95 | 55.37 | 108.13 | 162.65 |
Other Receivables | 3.05 | 0.44 | 6.64 | 10.26 | 18.93 | 147.56 |
Receivables | 87.75 | 71.42 | 69.59 | 65.63 | 127.06 | 310.21 |
Inventory | 154.8 | 174 | 297.11 | 333.5 | 394.5 | 440.43 |
Other Current Assets | 184.77 | 164.77 | 209.61 | 245.9 | 273.31 | 280.11 |
Total Current Assets | 555.34 | 618.15 | 749.24 | 816 | 994.46 | 1,243 |
Property, Plant & Equipment | 246.31 | 262.15 | 296.42 | 281.18 | 296.92 | 314.39 |
Long-Term Investments | 51.89 | 51.89 | 89 | 228.97 | 270.96 | 345.14 |
Other Intangible Assets | 73.29 | 74.29 | 83.25 | 84.68 | 145.78 | 166.36 |
Long-Term Deferred Tax Assets | 34.19 | 38.62 | 31.34 | 30.83 | 23 | 18.97 |
Long-Term Deferred Charges | 6.64 | 6.63 | 8.08 | 2.33 | 3.13 | 3.72 |
Other Long-Term Assets | 112.22 | 112.56 | 101.99 | 115.24 | 113.87 | 114.33 |
Total Assets | 1,080 | 1,164 | 1,359 | 1,559 | 1,848 | 2,206 |
Accounts Payable | 1.57 | 9.09 | 6.77 | 2.67 | 3.74 | 122 |
Accrued Expenses | 1.73 | 16.35 | 17.2 | 9.01 | 7.21 | 2.78 |
Current Portion of Leases | 4.58 | 8.82 | 8.83 | 1.95 | 0.55 | - |
Current Income Taxes Payable | 2.47 | 2.07 | 2.17 | - | - | 1.3 |
Current Unearned Revenue | 20.6 | 83.66 | 40.44 | 2.31 | 9.63 | 1.44 |
Other Current Liabilities | 13.87 | 4.55 | 5.73 | 5.79 | 3.59 | 6.48 |
Total Current Liabilities | 44.82 | 124.55 | 81.14 | 21.73 | 24.7 | 133.99 |
Long-Term Leases | 0.05 | 2.98 | 9.83 | 2.95 | 0.58 | - |
Long-Term Unearned Revenue | 0.48 | 0.5 | 1.01 | 1.63 | 2.36 | 3.09 |
Long-Term Deferred Tax Liabilities | - | - | 0 | - | - | - |
Total Liabilities | 45.34 | 128.02 | 91.99 | 26.3 | 27.64 | 137.08 |
Common Stock | 587.06 | 587.06 | 587.06 | 587.06 | 587.06 | 587.06 |
Additional Paid-In Capital | 237.37 | 237.37 | 237.37 | 237.37 | 237.37 | 237.37 |
Retained Earnings | 239.03 | 241.86 | 440.63 | 708.5 | 996.04 | 1,245 |
Treasury Stock | -33.75 | -33.75 | - | - | - | - |
Total Common Equity | 1,030 | 1,033 | 1,265 | 1,533 | 1,820 | 2,069 |
Minority Interest | 4.82 | 3.71 | 2.25 | -0 | - | - |
Shareholders' Equity | 1,035 | 1,036 | 1,267 | 1,533 | 1,820 | 2,069 |
Total Liabilities & Equity | 1,080 | 1,164 | 1,359 | 1,559 | 1,848 | 2,206 |
Total Debt | 4.62 | 11.8 | 18.66 | 4.9 | 1.13 | - |
Net Cash (Debt) | 123.4 | 196.16 | 154.27 | 166.09 | 198.46 | 212.5 |
Net Cash Growth | -5.95% | 27.15% | -7.11% | -16.31% | -6.61% | -37.11% |
Net Cash Per Share | 0.22 | 0.34 | 0.26 | 0.28 | 0.34 | 0.36 |
Filing Date Shares Outstanding | 572.36 | 572.36 | 587.06 | 587.06 | 587.06 | 587.06 |
Total Common Shares Outstanding | 572.36 | 572.36 | 587.06 | 587.06 | 587.06 | 587.06 |
Working Capital | 510.53 | 493.61 | 668.09 | 794.28 | 969.75 | 1,109 |
Book Value Per Share | 1.80 | 1.80 | 2.15 | 2.61 | 3.10 | 3.52 |
Tangible Book Value | 956.43 | 958.26 | 1,182 | 1,448 | 1,675 | 1,903 |
Tangible Book Value Per Share | 1.67 | 1.67 | 2.01 | 2.47 | 2.85 | 3.24 |
Buildings | - | 306.66 | 319.75 | 298.95 | 301.11 | 301.11 |
Machinery | - | 110.16 | 107.22 | 106.11 | 105.92 | 104.33 |
Construction In Progress | - | - | - | 1.28 | - | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.